Skip to Content

IDEXX Laboratories Inc IDXX Stock Quote

| Rating as of


Morningstar‘s Stock Analysis IDXX

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Idexx Flexes Its Pricing Power and Meets Little Resistance; Our Fair Value Estimate Is Unchanged

Debbie S. Wang Senior Equity Analyst

Analyst Note

| Debbie Wang |

Idexx Labs saw solid results in the third quarter that featured strength in companion animal diagnostics as well as the smaller water segment. We made minor adjustments to our full-year projections to further reflect unfavorable foreign exchange, but these weren’t material enough to shift our fair value estimate. Coming off the pandemic-fueled boost in business in 2020 and 2021, Idexx is now shifting gears for growth that resembles that of the prepandemic days, albeit off a larger pool of pets. Shares remain overvalued, in our view. Thanks to inflationary conditions, Idexx has also rolled out price increases, and thus far doesn’t seem to have received much push back from vets. We view Idexx’s ability to flex its pricing upward as indicative of the firm’s narrow economic moat. The switching costs associated with its benchtop analyzers and practice management software, as well as intangible assets in the form of close relationships with vets, translate into pricing power for Idexx, from our perspective.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics IDXX

Company Profile IDXX

Business Description

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

One IDEXX Drive
Westbrook, ME, 04092
Industry Diagnostics & Research
Employees 10,350

Related Articles IDXX

FAQs for IDEXX Laboratories Inc Stock

No. IDXX does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

IDXX’s market cap is 34.40 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

IDXX’s stock style is Mid Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

IDXX’s price/sales is 10.59.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

IDXX’s price/forward earnings is 48.54.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

IDXX’s price/book is 72.27.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See IDXX’s valuation ratios compared to the Market Index.

IDXX’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare IDXX’s historical performance against its industry peers and the overall market.